Molsidomine prevents post-ischaemic ventricular fibrillation in dogs

British Journal of Pharmacology
J P CanoA Serradimigni

Abstract

Forty anaesthetized dogs were subjected to left circumflex coronary artery ligation followed by reperfusion. Molsidomine was randomly administered to 20 dogs (50 micrograms kg-1 as an i.v. bolus - 15 min prior to coronary occlusion - followed by an infusion of 0.05 micrograms kg-1 min-1. Standard electrocardiographic leads 2 and 3 were continuously recorded to measure ST segment and delta R% changes and to document both the number of ventricular premature beats and the onset of ventricular fibrillation; aortic pressure and cardiac output were measured; thromboxane B2 plasma levels, platelet aggregation produced by ADP, and molsidomine plasma levels were determined before and at 10, 30 and 75 min after the start of the drug protocol. Molsidomine protected the treated animals from early (10 min) post-ischaemic ventricular fibrillation (0 of 20 vs 6 of 20, P = 0.0202), reduced the incidence of overall post-occlusion ventricular fibrillation (3 of 20 vs 10 of 20, P = 0.0407) and improved the total survival rate (P = 0.0067). In molsidomine treated dogs: mean aortic pressure and the rate-pressure product were lowered 10 min after the start of the drug; immediate post-occlusion (3 min) ST segment changes (0.82 +/- 0.52 vs 1.52 +/- 0....Continue Reading

References

Jun 19, 1978·European Journal of Clinical Pharmacology·S GuerchicoffF Díaz
Nov 1, 1978·Journal of Chromatography·D Dell, J Chamberlain
Jan 1, 1986·Journal of Cardiovascular Pharmacology·R JouveA Serradimigni
Mar 1, 1985·American Heart Journal·W R Kukovetz, S Holzmann
Mar 1, 1985·American Heart Journal·R E Nitz, P A Martorana
Jan 1, 1968·The American Journal of Cardiology·H I Russek
Sep 1, 1982·Journal of Cardiovascular Pharmacology·V A StarnesJ W Hammon
Jan 1, 1984·European Journal of Clinical Pharmacology·A E BalestriniA Vazquez
Sep 1, 1983·European Heart Journal·K BalakumaranD R Chadha
Oct 1, 1983·Journal of Electrocardiology·J TorresaniR Jouve
May 1, 1984·The American Journal of Cardiology·S L HaleR A Kloner
Aug 1, 1982·Journal of Molecular and Cellular Cardiology·S J CokerI J Zeitlin
Aug 1, 1982·Canadian Journal of Physiology and Pharmacology·V B Fiedler
Dec 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·V B FiedlerR E Nitz
Jan 3, 1980·The New England Journal of Medicine·P A MajidJ P Roos
Oct 1, 1982·British Journal of Pharmacology·P Duchene-MarullazJ P Kantelip

❮ Previous
Next ❯

Citations

Dec 6, 2016·Canadian Journal of Physiology and Pharmacology·Michał ŻorniakTadeusz F Krzemiński
Apr 1, 1997·Journal of Cardiovascular Pharmacology·W Sun, C L Wainwright
Jan 1, 1987·Pharmacotherapy·R E Nitz, V B Fiedler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.